✦ LIBER ✦

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency

✍ Scribed by Wasserman, Richard L.; Church, Joseph A.; Stein, Mark; Moy, James; White, Martha; Strausbaugh, Steven; Schroeder, Harry; Ballow, Mark; Harris, James; Melamed, Isaac; Elkayam, David; Lumry, William; Suez, Daniel; Rehman, Syed M.

Book ID: 113070554
Publisher: Springer
Year: 2012
Tongue: English
Weight: 154 KB
Volume: 32
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-012-9656-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, efficacy, tolerability, and phar

Safety, efficacy, tolerability, and pharmacokinetics of a new liquid intravenous immunoglobulin (IVIG) in comparison to Sandoglobulin® in patients with primary immunodeficiencies (PID)

✍ Borte, M.; Wahn, U.; Farber, C.; Bernatowska, E.; Adams, C.; Andresen, I.; Bende 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Safety and Efficacy of Privigen®, a Nove

Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies

✍ Mark R. Stein; Robert P. Nelson; Joseph A. Church; Richard L. Wasserman; Michael 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB

Efficacy, Safety and Tolerability of a N

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB

A 10% liquid immunoglobulin preparation

A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG

✍ Lozano-Blasco, J.; Martín-Mateos, M.A.; Alsina, L.; Domínguez, O.; Giner, M.T.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Efficacy, Pharmacokinetics, Safety, and

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

✍ Melvin Berger; Paul J. Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Safety and Efficacy of a Novel Liquid 10

Safety and Efficacy of a Novel Liquid 10% Immunoglobulin Preparation (Privigen) for Intravenous Use in Primary Immunodeficiency

✍ STEIN, M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 39 KB